Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
41.17
+0.37 (0.91%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Nektar Therapeutics Employees
Nektar Therapeutics had 63 employees as of December 31, 2025. The number of employees increased by 2 or 3.28% compared to the previous year. That makes Nektar Therapeutics the 33,891st largest employer in the world and 4,487th in the United States.
Employees
63
Change (1Y)
2
Growth (1Y)
3.28%
Revenue / Employee
$866,492
Profits / Employee
-$2,494,079
Market Cap
1.41B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 63 | 2 | 3.28% |
| Dec 31, 2024 | 61 | -76 | -55.47% |
| Dec 31, 2023 | 137 | -79 | -36.57% |
| Dec 31, 2022 | 216 | -524 | -70.81% |
| Dec 31, 2021 | 740 | 22 | 3.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 828 |
| Kardigan | 241 |
| Omeros | 175 |
| Maze Therapeutics | 141 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
| Taysha Gene Therapies | 99 |
| Tyra Biosciences | 87 |
NKTR News
- 2 days ago - 3 ‘Strong Buy’ High-Risk/High-Reward Stocks to Bank on for 100%+ Upside Potential - TipRanks
- 3 days ago - Nektar initiated with a Market Perform at Raymond James - TheFly
- 6 days ago - Nektar 60% selloff brings ‘attractive buying opportunity,’ says Citi - TheFly
- 9 days ago - Nektar selloff yesterday overdone, says H.C. Wainwright - TheFly
- 10 days ago - Nektar selloff after rezpegaldesleukin data ‘unwarranted,’ says Jefferies - TheFly
- 10 days ago - William Blair says rezpeg data a positive for Nektar - TheFly
- 10 days ago - Nektar falls -21.6% - TheFly
- 10 days ago - Nektar Stock Sinks Despite Promising Hair Loss Treatment Data - Barrons